Evidence method
Level · gp.fundamentals.capex_revenue_ratio
4.46% · OPTIONAL · NOT_ENOUGH_HISTORY
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME
SBFM · Dec 31, 2022
Sunshine Biopharma Inc.. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.
STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration
State dimensions
Filing0001683168-23-002128General Corporate
Evidence method
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
-120.77% · OPTIONAL · VALID
Evidence method
Yoy · gp.fundamentals.revenue
1802.41% · CORE · VALID
Evidence method
Level · gp.fundamentals.inventory_revenue_ratio
75.71% · OPTIONAL · VALID
Evidence method
Level · gp.fundamentals.gross_margin
39.04% · CORE · VALID
Evidence method
Level · gp.fundamentals.operating_margin
-621.33% · CORE · VALID
Evidence method
Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
18.68% · OPTIONAL · VALID
As-filed lineage
Fundamental state history
Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History30 statesSelf-history eligible
Dec 31, 20214/7 normalizedLevel 3Mar 31, 20225/6 normalizedLevel 3Jun 30, 20226/6 normalizedLevel 3Sep 30, 20226/6 normalizedLevel 3Dec 31, 20226/7 normalizedLevel 3Mar 31, 20236/6 normalizedLevel 3Jun 30, 20236/6 normalizedLevel 3Sep 30, 20236/7 normalizedLevel 3Dec 31, 20236/7 normalizedLevel 3Mar 31, 20246/6 normalizedLevel 3Jun 30, 20246/6 normalizedLevel 3Jun 30, 20246/6 normalizedAmended as filedSep 30, 20246/6 normalizedLevel 3Dec 31, 20247/7 normalizedLevel 3Mar 31, 20257/7 normalizedLevel 3Jun 30, 20257/7 normalizedLevel 3Sep 30, 20257/7 normalizedLevel 3Dec 31, 20257/7 normalizedLevel 3Mar 31, 20267/7 normalizedLevel 3Jun 30, 20267/7 normalizedLevel 4
Period transition
What moved in the state?
- Previous
- -846.14%
- Current
- -120.77%
- Delta
- 725.36%
- Previous
- 163.63%
- Current
- 1802.41%
- Delta
- 1638.78%
- Previous
- 203.03%
- Current
- 75.71%
- Delta
- -127.32%
- Previous
- 50.47%
- Current
- 39.04%
- Delta
- -11.43%
- Previous
- -1293.58%
- Current
- -621.33%
- Delta
- 672.25%
- Previous
- 272.95%
- Current
- 18.68%
- Delta
- -254.27%
Self-history only
Previous similar states
Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research
Transitioned To · SBFM Fundamental State →Transitioned To · SBFM Fundamental State →Transitioned To · SBFM CASH_GENERATION_INCREASED →Transitioned To · SBFM GROWTH_INCREASED →Transitioned To · SBFM INVENTORY_PRESSURE_DECREASED →Transitioned To · SBFM MARGIN_DECREASED →Transitioned To · SBFM PROFITABILITY_INCREASED →Transitioned To · SBFM R_AND_D_INTENSITY_DECREASED →
Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.